About the Product

Description


Flufenol M Tablet containing Flupentixol and Melitracen is used for the management of depression, anxiety, and mood-related disorders. It helps improve emotional stability and mental well-being.

Flupentixol acts as a mild mood stabilizer and antipsychotic agent, while Melitracen helps enhance mood, reduce anxiety, and improve emotional balance.

The tablet is widely prescribed in psychiatry and general medicine practice for mild to moderate depression and anxiety conditions, leading to consistent prescription demand.

With increasing stress levels, anxiety disorders, and lifestyle-related mental health concerns, this product offers strong business potential for retailers and distributors. Its combined antidepressant and anxiolytic action, broad therapeutic relevance, and steady market demand make it a reliable product for growth in the CNS care segment.

Common side effects include drowsiness, dry mouth, dizziness, and gastrointestinal discomfort. Rarely, it may cause restlessness or allergic reactions. Seek medical advice if side effects persist or worsen.

Indicated for the treatment of mild to moderate anxiety and depression.

Use only under medical supervision. Avoid alcohol during treatment. Do not stop the medication abruptly without consulting your doctor.

Store at a temperature below 30°C in a cool, dry place, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Flupenthixol 0.5mg + Melitracen 10mg Tablet in the PCD pharma franchise market?

This combination tablet is used for depression, anxiety disorders, and psychosomatic conditions, making it a strong CNS and psychiatry segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and wholesalers can benefit from steady demand in psychiatry clinics, general physician prescriptions, and long-term mood disorder management. It is commonly prescribed for anxiety with depressive symptoms and stress-related disorders.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Flupenthixol + Melitracen Tablet with monopoly rights, quality psychiatric formulations, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this CNS psychiatric product?

Wholesalers and medical agencies benefit from long-term prescription cycles, consistent psychiatry demand, and repeat patient therapy usage in mental health treatment when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this psychiatric combination tablet?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this CNS formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.